BridgeBio Pharma (BBIO) Change in Intangibles (2024 - 2025)

BridgeBio Pharma's (BBIO) quarterly Change in Intangibles came in at $2.4 million in Q3 2025, up 50.47% year-on-year from $1.6 million in Q3 2024, and down 46.67% quarter-over-quarter from $4.5 million in Q2 2025.

BridgeBio Pharma (BBIO) Change in Intangibles (2024 - 2025) Analysis & Trends

BridgeBio Pharma has disclosed Change in Intangibles across 2 years of filings, most recently posting $2.4 million for Q3 2025.

  • Change in Intangibles for Q3 2025 came in at $2.4 million, up 50.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.9 million (down 21.35% YoY), and the FY2025 annual result was $8.5 million, up 6.52% from the prior year.
  • Change in Intangibles came in at $2.4 million for Q3 2025 at BridgeBio Pharma, down from $4.5 million in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $4.5 million in Q2 2025 to a low of $797000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.96 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 BridgeBio Pharma 12.90 Bn 11.97 Bn 184.58 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 2.40 Mn
Sep 30, 2025 2.40 Mn
Jun 30, 2025 4.50 Mn
Jun 30, 2025 4.50 Mn
Mar 31, 2025 1.60 Mn
Mar 31, 2025 1.60 Mn
Dec 31, 2024 3.19 Mn
Dec 31, 2024 3.19 Mn
Sep 30, 2024 1.60 Mn
Sep 30, 2024 1.60 Mn
Jun 30, 2024 2.39 Mn
Jun 30, 2024 2.39 Mn
Mar 31, 2024 797,000.00
Mar 31, 2024 797,000.00